IDH1 blocking peptide

Catalogue Number: GTX31417-PEP-GTX

Manufacturer:GeneTex
Preservative:0.02% Sodium azide|0.02% Sodium azide
Physical state:Liquid
Type:Blocking Peptides
Alias:Isocitrate Dehydrogenase (Nadp(+)) 1, Cytosolic , Hel-216 , Hel-S-26 , Idcd , Idh , Idp , Idpc , Picd , Idh1
Shipping Condition:Dry Ice
Unit(s): 50 ug
Application: NT, Inh

Description

Description: Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the cytoplasm and peroxisomes. It contains the PTS-1 peroxisomal targeting signal sequence. The presence of this enzyme in peroxisomes suggests roles in the regeneration of NADPH for intraperoxisomal reductions, such as the conversion of 2, 4-dienoyl-CoAs to 3-enoyl-CoAs, as well as in peroxisomal reactions that consume 2-oxoglutarate, namely the alpha-hydroxylation of phytanic acid. The cytoplasmic enzyme serves a significant role in cytoplasmic NADPH production. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2013]

Additional Text

Gene Name

IDH1

Concentration

200 ug/ml

Gene ID

3417

Note

For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption

Short Description

IDH1 peptide is used for blocking the activity of IDH1 antibody (catalog number GTX31417).

Storage Note

Store as concentrated solution. Aliquot and store at -20C or below. Avoid freeze-thaw cycles.